These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4001725)

  • 1. Universal immunization to interrupt rubella.
    Bart KJ; Orenstein WA; Preblud SR; Hinman AR
    Rev Infect Dis; 1985; 7 Suppl 1():S177-84. PubMed ID: 4001725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The opportunity and obligation to eliminate rubella from the United States.
    Orenstein WA; Bart KJ; Hinman AR; Preblud SR; Greaves WL; Doster SW; Stetler HC; Sirotkin B
    JAMA; 1984 Apr; 251(15):1988-94. PubMed ID: 6700103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimum use of rubella immunization.
    Mayer TR
    Am Fam Physician; 1981 Jan; 23(1):143-5. PubMed ID: 7457312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).
    McLean HQ; Fiebelkorn AP; Temte JL; Wallace GS;
    MMWR Recomm Rep; 2013 Jun; 62(RR-04):1-34. PubMed ID: 23760231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective immunization: protection of the individual.
    Dudgeon JA
    Rev Infect Dis; 1985; 7 Suppl 1():S185-90. PubMed ID: 4001726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of rubella and congenital rubella infection in Israel, a country with a selective immunization program.
    Swartz TA; Hornstein L; Epstein I
    Rev Infect Dis; 1985; 7 Suppl 1():S42-6. PubMed ID: 4001732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of rubella in the United States, 1969-1975.
    Hayden GF; Modlin JF; Witte JJ
    J Infect Dis; 1977 Feb; 135(2):337-40. PubMed ID: 839093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rubella. Increase in rubella and congenital rubella syndrome, 1988-1990.
    Wkly Epidemiol Rec; 1991 May; 66(18):128-31. PubMed ID: 2039689
    [No Abstract]   [Full Text] [Related]  

  • 9. Elimination of rubella and congenital rubella from the United States.
    Bart KJ; Orenstein WA; Preblud SR; Hinman AR; Lewis FL; Williams NM
    Pediatr Infect Dis; 1985; 4(1):14-21. PubMed ID: 3969361
    [No Abstract]   [Full Text] [Related]  

  • 10. An outbreak of congenital rubella in Chicago.
    Lamprecht C; Schauf V; Warren D; Nelson K; Northrop R; Christiansen M
    JAMA; 1982 Feb; 247(8):1129-33. PubMed ID: 7057601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of rubella in Israel: progress and challenge.
    Slater PE; Roitman M; Leventhal A; Anis E
    Public Health Rev; 1996; 24(2):183-92. PubMed ID: 8918184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rubella immunization strategies in Canada.
    Furesz J; Varughese P; Acres SE; Davies JW
    Rev Infect Dis; 1985; 7 Suppl 1():S191-3. PubMed ID: 4001727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RUBELLA--SHOULD IT BE A PRIORITY IN THE NATIONAL IMMUNIZATION PROGRAMMES?
    Wazir MS; Iqbal S
    J Ayub Med Coll Abbottabad; 2015; 27(4):747-8. PubMed ID: 27004313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rubella immunization of hospital personnel: a debate.
    Evans ME; Schaffner W
    Infect Control; 1981; 2(5):387-90. PubMed ID: 6913547
    [No Abstract]   [Full Text] [Related]  

  • 15. Rubella control in Papua New Guinea: age-specific immunity informs strategies for introduction of rubella vaccine.
    Riddell M; Senn N; Clements CJ; Hobday L; Cowie B; Kurubi J; Kevin A; Siba P; Reeder JC; Morgan C
    Vaccine; 2012 Dec; 30(52):7506-12. PubMed ID: 23103194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated rubella and congenital rubella syndrome programme, Costa Rica.
    Wkly Epidemiol Rec; 2001 Aug; 76(35):265-70. PubMed ID: 11565150
    [No Abstract]   [Full Text] [Related]  

  • 17. Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 2: Vaccination against rubella.
    Robertson SE; Cutts FT; Samuel R; Diaz-Ortega JL
    Bull World Health Organ; 1997; 75(1):69-80. PubMed ID: 9141752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Informing rubella vaccination strategies in East Java, Indonesia through transmission modelling.
    Wu Y; Wood J; Khandaker G; Waddington C; Snelling T
    Vaccine; 2016 Nov; 34(46):5636-5642. PubMed ID: 27670077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rubella (German measles) revisited.
    Leung AKC; Hon KL; Leong KF
    Hong Kong Med J; 2019 Apr; 25(2):134-141. PubMed ID: 30967519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.